IRIS Accounts Production v25.1.0.734 SC566480 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC5664802024-03-31SC5664802025-03-31SC5664802024-04-012025-03-31SC5664802023-03-31SC5664802023-04-012024-03-31SC5664802024-03-31SC566480ns15:Scotland2024-04-012025-03-31SC566480ns14:PoundSterling2024-04-012025-03-31SC566480ns10:Director12024-04-012025-03-31SC566480ns10:PrivateLimitedCompanyLtd2024-04-012025-03-31SC566480ns10:SmallEntities2024-04-012025-03-31SC566480ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-31SC566480ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-31SC566480ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-31SC566480ns10:FullAccounts2024-04-012025-03-31SC56648012024-04-012025-03-31SC566480ns10:Director22024-04-012025-03-31SC566480ns10:RegisteredOffice2024-04-012025-03-31SC566480ns5:CurrentFinancialInstruments2025-03-31SC566480ns5:CurrentFinancialInstruments2024-03-31SC566480ns5:Non-currentFinancialInstruments2025-03-31SC566480ns5:Non-currentFinancialInstruments2024-03-31SC566480ns5:ShareCapital2025-03-31SC566480ns5:ShareCapital2024-03-31SC566480ns5:SharePremium2025-03-31SC566480ns5:SharePremium2024-03-31SC566480ns5:RetainedEarningsAccumulatedLosses2025-03-31SC566480ns5:RetainedEarningsAccumulatedLosses2024-03-31SC566480ns5:NetGoodwill2024-04-012025-03-31SC566480ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-31SC566480ns5:FurnitureFittings2024-04-012025-03-31SC566480ns5:MotorVehicles2024-04-012025-03-31SC566480ns5:NetGoodwill2024-03-31SC566480ns5:NetGoodwill2025-03-31SC566480ns5:NetGoodwill2024-03-31SC566480ns5:FurnitureFittings2024-03-31SC566480ns5:MotorVehicles2024-03-31SC566480ns5:FurnitureFittings2025-03-31SC566480ns5:MotorVehicles2025-03-31SC566480ns5:FurnitureFittings2024-03-31SC566480ns5:MotorVehicles2024-03-31SC566480ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC566480ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31SC566480ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2025-03-31SC566480ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-03-31SC566480ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2025-03-31SC566480ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-03-31SC566480ns5:HirePurchaseContracts2025-03-31SC566480ns5:HirePurchaseContracts2024-03-31SC566480ns10:Director222024-03-31SC566480ns10:Director222023-03-31SC566480ns10:Director222024-04-012025-03-31SC566480ns10:Director222023-04-012024-03-31SC566480ns10:Director222025-03-31SC566480ns10:Director222024-03-31
REGISTERED NUMBER: SC566480 (Scotland)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

R W WILSON PHARMACY LTD

R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


R W WILSON PHARMACY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: J Currie
J Deeney



REGISTERED OFFICE: Stanley House
69/71 Hamilton Road
Motherwell
ML13DG



REGISTERED NUMBER: SC566480 (Scotland)



ACCOUNTANTS: McDaid & Partners
Stanley House
69/71 Hamilton Road
Motherwell
Lanarkshire
ML1 3DG



TRADING ADDRESS: 50 Front Street
Winlaton
Tyne & Wear
NE21 6AD

R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 57,786 80,901
Tangible assets 5 59,625 53,370
117,411 134,271

CURRENT ASSETS
Stocks 39,919 36,382
Debtors 6 158,773 151,803
Cash at bank and in hand 402,588 358,287
601,280 546,472
CREDITORS
Amounts falling due within one year 7 175,987 193,285
NET CURRENT ASSETS 425,293 353,187
TOTAL ASSETS LESS CURRENT
LIABILITIES

542,704

487,458

CREDITORS
Amounts falling due after more than one
year

8

(7,063

)

-

PROVISIONS FOR LIABILITIES (21,317 ) (17,041 )
NET ASSETS 514,324 470,417

CAPITAL AND RESERVES
Called up share capital 266 266
Share premium 301,789 301,789
Retained earnings 212,269 168,362
514,324 470,417

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 4 July 2025 and were signed on its behalf by:





J Currie - Director


R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

R W Wilson Pharmacy Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is stated net of value added tax for over the counter sales and gross for NHS sales. Turnover from the sale of over the counter goods is recognised when the payment is recorded in the till and NHS Income is recognised when the client receives a PPD9 confirming the sale.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2017, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures & fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Basic financial instruments
Trade debtors
Trade debtors are amounts due from customers for goods or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade Creditors
Trade creditors are amounts due to suppliers for goods or services obtained in the ordinary course of business.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Cash
Cash and cash equivalents are basic financial assets and include cash on hand, deposits held at call with banks, other short-term liquid investments and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2024 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 231,149
AMORTISATION
At 1 April 2024 150,248
Charge for year 23,115
At 31 March 2025 173,363
NET BOOK VALUE
At 31 March 2025 57,786
At 31 March 2024 80,901

R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

5. TANGIBLE FIXED ASSETS
Fixtures Motor
& fittings vehicles Totals
£    £    £   
COST
At 1 April 2024 91,479 - 91,479
Additions - 18,500 18,500
At 31 March 2025 91,479 18,500 109,979
DEPRECIATION
At 1 April 2024 38,109 - 38,109
Charge for year 8,005 4,240 12,245
At 31 March 2025 46,114 4,240 50,354
NET BOOK VALUE
At 31 March 2025 45,365 14,260 59,625
At 31 March 2024 53,370 - 53,370

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 136,980 130,013
Other debtors 21,793 21,790
158,773 151,803

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Hire purchase contracts (see note 9) 5,650 -
Trade creditors 139,777 166,520
Taxation and social security 25,502 18,353
Other creditors 5,058 8,412
175,987 193,285

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.25 31.3.24
£    £   
Hire purchase contracts (see note 9) 7,063 -

R W WILSON PHARMACY LTD (REGISTERED NUMBER: SC566480)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

9. LEASING AGREEMENTS

Minimum lease payments under hire purchase fall due as follows:

Hire purchase contracts
31.3.25 31.3.24
£    £   
Net obligations repayable:
Within one year 5,650 -
Between one and five years 7,063 -
12,713 -

At the year end the company had total commitments under operating leases of £44,417 (2024 £52,617).

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
J Deeney
Balance outstanding at start of year 3,543 -
Amounts advanced 7,920 11,543
Amounts repaid (11,272 ) (8,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 191 3,543

Loans from the director are interest free and repayable on demand.